OriGene Technologies, Inc.
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Search Results

Your search returned 8 results.
Search:

SKU Category Vector Description Price Delivery
SC327258 Human cDNA pCMV6-XL5 KCNQ5 (untagged)-Human potassium voltage-gated channel KQT-like subfamily member 5 (KCNQ5) transcript variant 4 (10ug) NM_001160133.1 $1710 6-7 weeks
RC228623 Human ORF PS100001 KCNQ5 (Myc-DDK-tagged)-Human potassium voltage-gated channel, KQT-like subfamily, member 5 (KCNQ5), transcript variant 4 $1370 6-7 weeks
RC228623L1 Human ORF PS100064 Lenti-ORF clone of KCNQ5 (Myc-DDK-tagged)-Human potassium voltage-gated channel, KQT-like subfamily, member 5 (KCNQ5), transcript variant 4, (10ug) $1740 8-9 weeks
RC228623L2 Human ORF PS100071 Lenti-ORF clone of KCNQ5 (mGFP-tagged)-Human potassium voltage-gated channel, KQT-like subfamily, member 5 (KCNQ5), transcript variant 4, (10ug) $1910 8-9 weeks
RG228623 Human ORF PS100010 KCNQ5 (GFP-tagged) - Human potassium voltage-gated channel, KQT-like subfamily, member 5 (KCNQ5), transcript variant 4 $1510 6-7 weeks
TF303803 Human shRNA pRFP-C-RS KCNQ5 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector $650 7-9 Days
TG303803 Human shRNA pGFP-V-RS KCNQ5 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector $650 7-9 Days
TR303803 Human shRNA pRS KCNQ5 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector $650 7-9 Days
Inc 5000 Healthcare Company Copyright © 2014 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title